Nucleic Acid Labeling Market size is estimated to be $1.65 billion in 2019, growing at a CAGR of 8.5% during the forecast period 2020-2025.Rising geriatric population and the need of personalized medicines, increasing genomic and enzymology research and advancements in diagnostic tools for synthetic genome design and government initiatives for research and development in microbiology is a significant factor driving the nucleic acid labeling market during the forecast period 2020-2025.Nucleic acid may be modified with tags that enables detection and purification. The resulting nucleic acid probes can be used to identify or recover other interacting molecules. Common labels used to generated nucleic acid probe include radioactive phosphates, biotin, flurophores and enzymes.In addition the biconjugation method used for nucleic acid probe generation may be adapted for attaching molecules or surfaces to facilitate targeted delivery or immobilization. Nucleic acid labelling is a technique used to label nucleic acid for purification and visualization. In addition nucleic acid can be labelled at their 5’ end and 3’ end or throughout the molecule depending on a particular application to generate information on gene integrity and copy number, to diagnose specific sequences and chromosomal aberrations, to simultaneously measure the relative expressions of RNAs or to discover protein nucleic acid interactions. 

Key Takeaways

By Type Non-radioactive accounted for the largest market share in 2019 owing to its relative speed, sensitivity, safety and versatility.
Polymerase Chain Reaction accounted for the largest market share in 2019 owing to its sensivity that allows rapid amplification of a specific segment of DNA.
Increasing incidence of chronic diseases leading to diabetes and other cardiovascular diseases and the patients demand for personalized medicine is a major driving the Nucleic Acid Labeling Market during the forecast period 2020-2025.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=16748

Geography- Segment Analysis

North America dominated the Nucleic Acid Labeling Market with a region share 40% in 2019 followed by Europe and APAC. Rising geriatric population along with the increasing health expenditure and government initiative, increasing health concerns coupled with the growing demand of advanced treatment and a better healthcare structure is a major factor propelling its market growth. Furthermore, the presence of major players and ease of availability of technology advanced instruments in that region is further driving its market growth. 

Drivers – Nucleic Acid Labeling Market

Growing Demand for Personalized Medicine

Advancement in Tools for Synthetic Genome Design

Nucleic Acid Labeling Market top 10 companies are Enzo Biochem Inc, GE Healthcare, Marker Gene Technologies Inc, Merck KGaA, Thermofisher Scientific Inc, Vector Lavoratories Inc, Agilent Technologies, Promega Corporation, New England Biolabs and General Electric Company.

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.